Rishi Gupta - 12 Feb 2026 Form 4 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Role: Director
Signature: /s/ Ben Hohl, by power of attorney
Issuer symbol: ELVN
Transactions as of: 12 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 17 Feb 2026, 19:59:12 UTC
Previous filing: 08 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Gupta Rishi	Director	C/O ENLIVEN THERAPEUTICS, INC., 6200 LOOKOUT ROAD, BOULDER	/s/ Ben Hohl, by power of attorney	17 Feb 2026	0001537370

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELVN	Stock Option (right to buy)	Award	$0	+33,989		$0.000000	33,989	12 Feb 2026	Common Stock	33,989	$27.16	Direct	F1
transaction	ELVN	Stock Option (right to buy)	Award	$0	+1,580		$0.000000	1,580	12 Feb 2026	Common Stock	1,580	$27.16	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/36th of the shares subject to the option vest on February 2, 2026 and each month thereafter, subject to the Reporting Person continuing as a non-employee director through the applicable vesting date.
F2	100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2026 annual meeting of the Issuer's stockholders or (ii) the date of the 2027 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director through the applicable vesting date.